Foghorn Therapeutics (FHTX) Income Statement (2019 - 2026)
Income Statement report data from Sep 30, 2019 to Mar 31, 2026 for Foghorn Therapeutics (FHTX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||
Total Revenue | 3.27M (-64.65%) | 9.25M (+13.50%) | 8.15M (+7.80%) | 7.56M (+27.06%) | 5.95M (+108.04%) | 2.86M (-63.38%) | 7.81M (+13.35%) | 6.89M (+36.44%) | 5.05M (-12.48%) | 5.77M (-66.99%) | 17M (+212.14%) | 5.60M (+5.46%) | 5.31M (+27.03%) | 4.18M (-36.95%) | 6.63M (+47.66%) | 4.49M (+14.54%) | 3.92M (+452.11%) | 710K (+1675.00%) | 40K (-85.71%) | 280K (-3.45%) | 290K (+16.00%) | 250K (+38.89%) | 180K | - | - | - |
Operating Expenses | ||||||||||||||||||||||||||
Research And Development | 18M (-17.19%) | 22M (+10.25%) | 20M (-8.21%) | 22M (+0.74%) | 22M (+5.46%) | 21M (-16.93%) | 25M (+3.74%) | 24M (-6.78%) | 26M (+5.45%) | 24M (-7.77%) | 26M (-10.26%) | 29M (-2.47%) | 30M (+6.31%) | 28M (+4.75%) | 27M (+3.70%) | 26M (+5.96%) | 25M (+9.13%) | 22M (+9.61%) | 20M (+9.92%) | 19M (-0.48%) | 19M (+13.72%) | 16M (+2.23%) | 16M (+18.20%) | 14M (+18.52%) | 12M (+1.86%) | 11M |
Selling General And Administrative | 6.58M (-3.24%) | 6.80M (+2.26%) | 6.65M (-3.06%) | 6.86M (-5.25%) | 7.24M (+14.02%) | 6.35M (-8.90%) | 6.97M (-4.91%) | 7.33M (-4.93%) | 7.71M (+9.83%) | 7.02M (-15.52%) | 8.31M (-1.07%) | 8.40M (-2.78%) | 8.64M (+9.92%) | 7.86M (-1.38%) | 7.97M (+3.51%) | 7.70M (+6.65%) | 7.22M (+14.06%) | 6.33M (+8.95%) | 5.81M (+18.57%) | 4.90M (+4.48%) | 4.69M (+2.85%) | 4.56M (+78.13%) | 2.56M (+34.03%) | 1.91M (-13.96%) | 2.22M (+22.65%) | 1.81M |
Operating Expenses | 25M (-25.02%) | 33M (+24.32%) | 27M (-6.98%) | 29M (-0.76%) | 29M (+7.48%) | 27M (-15.16%) | 32M (-5.55%) | 34M (+0.84%) | 33M (+6.44%) | 31M (-9.64%) | 35M (-8.21%) | 38M (-2.54%) | 39M (+7.10%) | 36M (+3.38%) | 35M (+3.59%) | 34M (+6.18%) | 32M (+10.14%) | 29M (+9.51%) | 26M (+11.72%) | 24M (+0.51%) | 23M (+11.36%) | 21M (+12.64%) | 19M (+20.14%) | 16M (+13.27%) | 14M (+4.73%) | 13M |
Depreciation And Amortization | 240K (-66.20%) | 710K (-21.11%) | 900K (0.00%) | 900K (+8.43%) | 830K (+5.06%) | 790K (+12.86%) | 700K (-12.50%) | 800K (-4.76%) | 840K (-5.62%) | 890K (-1.11%) | 900K (+12.50%) | 800K (-6.98%) | 860K (+6.17%) | 810K (-10.00%) | 900K (+12.50%) | 800K (-1.23%) | 810K (-5.81%) | 860K (+7.50%) | 800K (0.00%) | 800K (+3.90%) | 770K (+35.09%) | 570K (+90.00%) | 300K (+50.00%) | 200K (-23.08%) | 260K | - |
Operating Income | ||||||||||||||||||||||||||
Operating Income | -21.57M (-9.67%) | -23.88M (+29.08%) | -18.50M (-12.32%) | -21.10M (-7.90%) | -22.91M (-4.54%) | -24.00M (+0.63%) | -23.85M (-10.44%) | -26.63M (-5.53%) | -28.19M (+10.72%) | -25.46M (+49.06%) | -17.08M (-46.71%) | -32.05M (-3.81%) | -33.32M (+4.48%) | -31.89M (+12.85%) | -28.26M (-3.19%) | -29.19M (+5.00%) | -27.80M (-1.00%) | -28.08M (+6.93%) | -26.26M (+12.90%) | -23.26M (+0.56%) | -23.13M (+11.31%) | -20.78M (+12.39%) | -18.49M (+18.98%) | -15.54M (+13.27%) | -13.72M (+4.73%) | -13.10M |
Ebit | -21.57M (-9.67%) | -23.88M (+29.08%) | -18.50M (-12.32%) | -21.10M (-7.90%) | -22.91M (-4.54%) | -24.00M (+0.63%) | -23.85M (-10.44%) | -26.63M (-5.53%) | -28.19M (+10.72%) | -25.46M (+49.06%) | -17.08M (-46.71%) | -32.05M (-3.81%) | -33.32M (+4.48%) | -31.89M (+12.85%) | -28.26M (-3.19%) | -29.19M (+5.00%) | -27.80M (-1.00%) | -28.08M (+6.93%) | -26.26M (+12.90%) | -23.26M (+0.56%) | -23.13M (+11.31%) | -20.78M (+12.39%) | -18.49M (+18.98%) | -15.54M (+13.27%) | -13.72M (+4.73%) | -13.10M |
EBITDA | -21.33M (-7.94%) | -23.17M (+31.65%) | -17.60M (-12.87%) | -20.20M (-8.56%) | -22.09M (-4.87%) | -23.22M (+0.30%) | -23.15M (-10.38%) | -25.83M (-5.59%) | -27.36M (+11.36%) | -24.57M (+51.85%) | -16.18M (-48.22%) | -31.25M (-3.73%) | -32.46M (+4.44%) | -31.08M (+13.60%) | -27.36M (-3.63%) | -28.39M (+5.19%) | -26.99M (-0.88%) | -27.23M (+6.95%) | -25.46M (+13.36%) | -22.46M (+0.45%) | -22.36M (+10.64%) | -20.21M (+11.11%) | -18.19M (+18.58%) | -15.34M (+13.88%) | -13.47M (+3.78%) | -12.98M |
Other Income / Expenses | ||||||||||||||||||||||||||
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 430K (-14.00%) | 500K (0.00%) | 500K (+2.04%) | 490K (+53.13%) | 320K (+60.00%) | 200K (0.00%) | 200K (-23.08%) | 260K (+136.36%) | 110K |
Net Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -430.00K (-14.00%) | -500.00K (+2.04%) | -490.00K (0.00%) | -490.00K (+53.13%) | -320.00K (+60.00%) | -200.00K (0.00%) | -200.00K (-23.08%) | -260.00K (+136.36%) | -110.00K |
Other Non Operating Income | 1.70M (-85.96%) | 12M (+356.98%) | 2.65M (-16.14%) | 3.16M (-22.55%) | 4.08M (-74.60%) | 16M (+239.53%) | 4.73M (+29.59%) | 3.65M (+14.78%) | 3.18M (-76.81%) | 14M (+295.10%) | 3.47M (-1.14%) | 3.51M (+3.54%) | 3.39M (+31.40%) | 2.58M (+3.61%) | 2.49M (+32.45%) | 1.88M (+111.24%) | 890K (-64.26%) | 2.49M (+1283.33%) | 180K (+20.00%) | 150K (+7.14%) | 140K | -270.00K | 120K | -180.00K (-21.74%) | -230.00K | 10K |
Net Income | ||||||||||||||||||||||||||
Income Before Tax | - | - | - | - | - | -19.50M (+1.99%) | -19.12M (-16.80%) | -22.98M (-8.15%) | -25.02M (+13.11%) | -22.12M (+62.53%) | -13.61M (-52.31%) | -28.54M (-4.64%) | -29.93M (+3.60%) | -28.89M (+12.11%) | -25.77M (-5.64%) | -27.31M (+1.49%) | -26.91M | - | - | - | - | - | - | - | - | - |
Income Tax Expense | - | - | - | - | - | - | - | - | - | 1.99M (+168.92%) | 740K (-21.28%) | 940K (+67.86%) | 560K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -19.87M (-8.26%) | -21.66M (+36.66%) | -15.85M (-11.65%) | -17.94M (-4.73%) | -18.83M (-3.44%) | -19.50M (+1.99%) | -19.12M (-16.80%) | -22.98M (-8.15%) | -25.02M (+3.77%) | -24.11M (+68.13%) | -14.34M (-51.37%) | -29.49M (-3.28%) | -30.49M (+5.54%) | -28.89M (+12.11%) | -25.77M (-5.64%) | -27.31M (+1.49%) | -26.91M (-7.65%) | -29.14M (+11.73%) | -26.08M (+12.85%) | -23.11M (+0.52%) | -22.99M (+10.74%) | -20.76M (+13.01%) | -18.37M (+16.86%) | -15.72M (+12.69%) | -13.95M (+6.57%) | -13.09M |
Net Income | -19.87M (-8.26%) | -21.66M (+36.66%) | -15.85M (-11.65%) | -17.94M (-4.73%) | -18.83M (-3.44%) | -19.50M (+1.99%) | -19.12M (-16.80%) | -22.98M (-8.15%) | -25.02M (+3.77%) | -24.11M (+68.13%) | -14.34M (-51.37%) | -29.49M (-3.28%) | -30.49M (+5.54%) | -28.89M (+12.11%) | -25.77M (-5.64%) | -27.31M (+1.49%) | -26.91M (-7.65%) | -29.14M (+11.73%) | -26.08M (+12.85%) | -23.11M (+0.52%) | -22.99M (+10.74%) | -20.76M (+13.01%) | -18.37M (+16.86%) | -15.72M (+12.69%) | -13.95M (+6.57%) | -13.09M |
Comprehensive Income Net Of Tax | -20.03M (-73.07%) | -74.39M (+371.42%) | -15.78M (-12.28%) | -17.99M (-5.07%) | -18.95M (-77.88%) | -85.66M (+365.04%) | -18.42M (-19.28%) | -22.82M (-7.57%) | -24.69M (-74.08%) | -95.27M (+604.66%) | -13.52M (-53.92%) | -29.34M (-0.10%) | -29.37M (-73.98%) | -112.86M (+311.30%) | -27.44M (-6.38%) | -29.31M (+4.31%) | -28.10M (-72.27%) | -101.32M (+288.50%) | -26.08M (+12.75%) | -23.13M (+0.70%) | -22.97M (-66.62%) | -68.81M (+274.58%) | -18.37M (+16.86%) | -15.72M (+12.69%) | -13.95M | - |